1. Hepatitis C in HIV-Infected Patients: Impact of Direct-Acting Antivirals

   • Kian Bichoupan
   • Douglas T. Dieterich

   Current Opinion 28 May 2014 Pages: 951 - 961

2. Gene Therapy for Primary Immunodeficiencies: Current Status and Future Prospects

   • Waseem Qasim
   • Andrew R. Gennery

   Leading Article 22 May 2014 Pages: 963 - 969

3. Defining the Role of Trimetazidine in the Treatment of Cardiovascular Disorders: Some Insights on Its Role in Heart Failure and Peripheral Artery Disease

   • Piotr Chrusciel
   • Jacek Rysz
   • Maciej Banach

   Review Article Open access 06 June 2014 Pages: 971 - 980

4. Innate Immune-Response Mechanisms in Dermatomyositis: An Update on Pathogenesis, Diagnosis and Treatment

   • Thorsten Hornung
   • Joerg Wenzel

   Review Article 11 June 2014 Pages: 981 - 998

   

5. Certolizumab Pegol: A Review of Its Use in Patients with Axial Spondyloarthritis or Psoriatic Arthritis

   • Sohita Dhillon

   Adis Drug Evaluation 12 June 2014 Pages: 999 - 1016

   

6. Deferasirox: A Review of Its Use for Chronic Iron Overload in Patients with Non-Transfusion-Dependent Thalassaemia

   • Matt Shirley
   • Greg L. Plosker

   Adis Drug Evaluation 12 June 2014 Pages: 1017 - 1027

   

7. Ustekinumab: A Review of Its Use in Psoriatic Arthritis

   • Kate McKeage

   Adis Drug Evaluation 12 June 2014 Pages: 1029 - 1039

   

8. Delamanid: First Global Approval

   • Nicola J. Ryan
   • Jin Han Lo

   R&D Insight Report 13 June 2014 Pages: 1041 - 1045

9. Ramucirumab: First Global Approval

   • Raewyn M. Poole
   • Asha Vaidya

   R&D Insight Report 12 June 2014 Pages: 1047 - 1058

10. Erratum to: Acotiamide: First Global Approval

    • Mary L. Nowlan
    • Lesley J. Scott

    Erratum 04 June 2014 Pages: 1059 - 1059

11. Erratum to: Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update

    • Abdullah Alsultan
    • Charles A. Peloquin

    Erratum 04 June 2014 Pages: 1061 - 1061